Ispire-Backed IKE Tech Invited to Participate in FDA Roundtable on PMTA Submissions

Core Insights - IKE Tech has been recognized by the FDA as a key stakeholder in the regulation of electronic nicotine delivery systems (ENDS), highlighting the importance of age-gating technology in future compliance efforts [2][4]. Group 1: FDA Roundtable Participation - IKE Tech has been invited to participate in an FDA roundtable discussion focused on the Premarket Tobacco Product Application (PMTA) process, which is limited to 30 companies nationwide [2]. - The roundtable aims to gather feedback from ENDS manufacturers regarding the PMTA submissions, addressing scientific, manufacturing, and operational considerations [5]. Group 2: Age-Gating Technology - IKE Tech is developing a blockchain-enabled, Bluetooth-based age-gating component that verifies legal-age access at the point of use, which is a significant advancement in regulatory compliance for ENDS products [4]. - The technology has been submitted for the first-ever component PMTA, positioning it as a potential enabling technology for next-generation regulatory compliance [4]. Group 3: Strategic Positioning - Ispire's investment in IKE Tech places the company at the center of regulatory discussions, emphasizing the role of innovation in strengthening compliance and protecting youth [5]. - The FDA's engagement with IKE Tech indicates that age-gating is becoming a central concept in the regulatory landscape for ENDS products [4]. Group 4: Company Overview - IKE Tech LLC is a joint venture founded in 2024, focusing on building identity solutions using patented technologies in blockchain authentication and secure communication [6]. - Ispire Technology Inc. is involved in the research, development, and commercialization of vaping products, holding over 400 patents globally [8].